LJAC
XBI icon

L.J. Altfest & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

L.J. Altfest & Co’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Buy
74,627
+40,726
+120% +$5.51M 1.15% 23
2026
Q1 		$4.33M Sell
33,901
-108,270
-76% -$13.5M 0.46% 48
2025
Q4 		$17.3M Buy
142,171
+17,250
+14% +$1.98M 1.9% 14
2025
Q3 		$12.5M Buy
124,921
+48,326
+63% +$4.35M 1.4% 18
2025
Q2 		$6.35M Buy
76,595
+49,309
+181% +$3.93M 0.75% 29
2025
Q1 		$2.21M Sell
27,286
-1,055
-4% -$94.3K 0.28% 65
2024
Q4 		$2.55M Sell
28,341
-17,757
-39% -$1.72M 0.33% 62
2024
Q3 		$4.55M Buy
46,098
+6,105
+15% +$600K 0.61% 33
2024
Q2 		$3.71M Buy
39,993
+7,881
+25% +$707K 0.51% 36
2024
Q1 		$3.05M Sell
32,112
-3,774
-11% -$350K 0.43% 40
2023
Q4 		$3.2M Buy
35,886
+6,205
+21% +$461K 0.46% 44
2023
Q3 		$2.17M Sell
29,681
-11,894
-29% -$950K 0.34% 46
2023
Q2 		$3.46M Buy
41,575
+9,256
+29% +$774K 0.52% 36
2023
Q1 		$2.46M Buy
32,319
+2,395
+8% +$199K 0.39% 39
2022
Q4 		$2.48M Buy
29,924
+554
+2% +$44.9K 0.41% 50
2022
Q3 		$2.33M Buy
+29,370
New +$2.48M 0.44% 39
2022
Q2 		– Sell
-3,066
Closed -$276K – 284
2022
Q1 		$276K Buy
3,066
+762
+33% +$70.4K 0.05% 213
2021
Q4 		$258K Sell
2,304
-6,321
-73% -$762K 0.05% 218
2021
Q3 		$1.08M Buy
8,625
+6,419
+291% +$827K 0.23% 76
2021
Q2 		$299K Sell
2,206
-5
-0.2% -$657 0.06% 211
2021
Q1 		$300K Sell
2,211
-140
-6% -$21K 0.07% 205
2020
Q4 		$331K Hold
2,351
– – 0.08% 188
2020
Q3 		$262K Sell
2,351
-3
-0.1% -$336 0.07% 184
2020
Q2 		$264K Sell
2,354
-5,485
-70% -$540K 0.08% 177
2020
Q1 		$607K Buy
7,839
+5,391
+220% +$477K 0.19% 88
2019
Q4 		$233K Sell
2,448
-292
-11% -$25.3K 0.06% 178
2019
Q3 		$209K Hold
2,740
– – 0.05% 176
2019
Q2 		$240K Sell
2,740
-209
-7% -$17.8K 0.06% 166
2019
Q1 		$267K Sell
2,949
-22,461
-88% -$1.91M 0.07% 157
2018
Q4 		$1.82M Buy
25,410
+4,874
+24% +$393K 0.51% 31
2018
Q3 		$1.97M Sell
20,536
-37
-0.2% -$3.59K 0.57% 31
2018
Q2 		$1.96M Sell
20,573
-4,552
-18% -$418K 0.73% 27
2018
Q1 		$2.2M Buy
25,125
+563
+2% +$51.4K 0.95% 21
2017
Q4 		$2.08M Buy
24,562
+15,501
+171% +$1.3M 0.79% 21
2017
Q3 		$784K Buy
+9,061
New +$726K 0.38% 69

Other funds holding XBI

MSR
Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
WT
Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $560M AUM 64.94% 1-Year Est. Return

L.J. Altfest & Co's XBI Position: Q2 2026 in Review

L.J. Altfest & Co increased its State Street SPDR S&P Biotech ETF (XBI) stake by 120% in Q2 2026, buying an estimated $5.51M and bringing the position to 74,627 shares worth $11.8M. The position accounts for 1.15% of the portfolio, ranked #23.

L.J. Altfest & Co first reported a position in XBI in Q3 2017 and has held it in 35 quarters since. The position peaked at $17.3M in Q4 2025. 393 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • L.J. Altfest & Co held 74,627 shares of State Street SPDR S&P Biotech ETF worth $11.8M as of Q2 2026.
  • L.J. Altfest & Co bought 40,726 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $5.51M.
  • State Street SPDR S&P Biotech ETF made up 1.15% of L.J. Altfest & Co's portfolio in Q2 2026, its #23 holding.
  • L.J. Altfest & Co first reported a position in State Street SPDR S&P Biotech ETF in Q3 2017 and has held it in 35 quarters since.
  • L.J. Altfest & Co's State Street SPDR S&P Biotech ETF position peaked at $17.3M in Q4 2025.
  • 393 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on L.J. Altfest & Co's 13F filing for Q2 2026, filed 30 Jul 2026.